| Literature DB >> 35544466 |
Brian Rice1,2, Sal Calo3,4, John Bosco Kamugisha2, Nicholas Kamara5, Stacey Chamberlain2,3.
Abstract
INTRODUCTION: Little data exists from sub-Saharan Africa describing incidence and outcomes of sepsis in emergency units and uncertainty exists surrounding optimal management of sepsis in low-income settings. There exists limited data regarding quality care metrics for non-physician clinicians trained in emergency care. The objective of this study was to describe changes in septic patients over time and evaluate associations between sepsis care and mortality.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35544466 PMCID: PMC9094533 DOI: 10.1371/journal.pone.0264517
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Patient visit inclusion and exclusion criteria.
Fig 2Annual emergency unit visits with suspected infection, qSOFA scores and malaria by year, 2010–2019.
Characteristics of non-septic (qSOFA = 0) and septic (qSOFA≥1) emergency unit patients with suspected infections (N = 17,490).
| No Sepsis (qSOFA = 0) | Sepsis (qSOFA≥1) | p-Value | |
|---|---|---|---|
| n = 7,053 | n = 10,437 | ||
|
| 44 (26–70) | 41 (27–64) | 0.0001 |
|
| |||
|
| 4893 (67.4) | 7835 (75.1) | <0.001 |
|
| 2111 (29.9) | 2541 (24.4) | <0.001 |
|
| 3406 (48.3) | 5724 (54.9) | <0.001 |
|
| 125.2 (124.8–125.6) | 107.6 (107.1–107.9) | <0.001 |
|
| 88.1 (87.6–88.5) | 98.8 (98.4–99.3) | <0.001 |
|
| 18.7 (18.7–18.8) | 26.1 (25.9–26.2) | <0.001 |
|
| 96.2 (96.0–96.3) | 93.8 (93.7–93.9) | <0.001 |
|
| |||
|
| 0 | 7664 (73.4) | <0.001 |
|
| 0 | 2369 (22.7) | <0.001 |
|
| 0 | 685 (6.6) | <0.001 |
|
| |||
|
| 897 (12.7) | 2016 (19.3) | <0.001 |
|
| 811 (11.5) | 1536 (14.7) | <0.001 |
|
| 423 (6.0) | 1554 (14.9) | <0.001 |
|
| |||
|
| 4536 (64.3) | 4168 (40.0) | <0.001 |
|
| 2429 (34.4) | 5858 (56.1) | <0.001 |
|
| 45 (0.6) | 337 (3.2) | <0.001 |
|
| |||
|
| 3594 (51.0) | 8332 (79.8) | <0.001 |
|
| 3421 (48.5) | 1982 (19.0) | <0.001 |
|
| 13 (0.2) | 70 (0.7) | <0.001 |
|
| 25 (0.4) | 54 (0.5) | 0.14 |
† Wilcoxon rank-sum used as test of significance
†† T-test used as test of significance
All others use Fisher’s exact test as test of significance
Interventions and mortality for patients 2012–2019 stratified by qSOFA score (n = 13,548).
| qSOFA Score | Dichotomous qSOFA Score | |||||||
|---|---|---|---|---|---|---|---|---|
| Zero | One | Two | Three | p-Value | No Sepsis (= 0) | Sepsis (≥ 1) | p-Value | |
|
| 5855 | 5331 | 2229 | 133 | n/a | 5855 | 7693 | n/a |
|
| 65 | 215 | 189 | 27 | n/a | 280 | 216 | n/a |
|
| 1.1 [0.9–1.4] | 4.0 [3.5–4.6] | 8.5 [7.4–9.7] | 20.3 [13.8–28.1] | <0.001 | 1.1 [0.8–1.4] | 5.6 [5.1–6.1] | <0.001 |
|
| ||||||||
| 3565 (60.9) | 2168 (40.7) | 505 (22.7) | 18 (13.5) | 0.08 | 3565 (60.9) | 2691 (35.0) | <0.001 | |
| 837 (14.3) | 1092 (20.5) | 528 (23.7) | 29 (21.8) | 0.009 | 837 (14.3) | 1649 (21.4) | <0.001 | |
| 794 (13.6) | 966 (18.1) | 380 (17.1) | 16 (12.0) | 0.004 | 794 (13.6) | 1362 (17.7) | <0.001 | |
| 659 (11.3) | 1105 (20.7) | 816 (36.6) | 70 (52.6) | 0.06 | 659 (11.3) | 1991 (25.9) | <0.001 | |
† ANOVA used as test of significance
†† T-test used as test of significance
* Anti-infectives include antibiotics, antivirals and/or antimalarials
** Fisher’s exact test used as test of significance
Fig 3Trends in sepsis management and sepsis mortality, 2012–2019.
Top graph shows proportion of sepsis management over time. Bottom graph shows sepsis mortality over time compared with non-sepsis mortality.
Fig 4Proportions and comparative mortality for sub-populations of septic (qSOFA≥1) patients, 2010–2019.
Logistic regression model of mortality in septic (qSOFA≥1) patients without malaria: 2012–2019 (N = 5,323).
| OR | 95% CI | p-Value | |||
|---|---|---|---|---|---|
| Age | |||||
| Additional Year (above 18) | 1.01 | 1.00 | - | 1.01 | 0.006 |
| HIV | |||||
| Negative | REF | ||||
| Positive | 1.63 | 1.2 | - | 2.2 | 0.002 |
| Gender | |||||
| M | REF | ||||
| F | 0.49 | 0.4 | - | 0.6 | <0.001 |
| Respiratory Status | |||||
| Normal Rate + No Hypoxia | REF | ||||
| Normal Rate + Hypoxia (SpO2<92%) | 1.35 | 0.9 | - | 2.0 | 0.129 |
| Tachypnea (≥22 bpm) + No Hypoxia | 1.69 | 1.0 | - | 3.0 | 0.069 |
| Tachypnea (≥22 bpm) + Hypoxia (SpO2<92%) | 4.57 | 3.1 | - | 6.7 | <0.001 |
| Heart Rate | |||||
| Normal | REF | ||||
| Tachycardic (≥100 bpm) | 1.35 | 1.0 | - | 1.7 | 0.023 |
| Temperature | |||||
| Hypothermic (≤ 35.5°C) | 1.78 | 1.3 | - | 2.4 | <0.001 |
| Normal | REF | ||||
| Febrile (≥ 37.5°C) | 0.58 | 0.4 | - | 0.8 | 0.002 |
| Blood Pressure | |||||
| Not Hypotensive | REF | ||||
| Hypotensive (SBP<100) | 1.63 | 1.3 | - | 2.1 | <0.001 |
| Mental Status | |||||
| Normal/Not Recorded | REF | ||||
| Altered | 1.36 | 1.0 | - | 1.9 | 0.081 |
| Clinical Impression | |||||
| "Not Sick" | REF | ||||
| "Sick" | 3.0 | 2.1 | - | 4.5 | <0.001 |
| "Toxic" | 17.6 | 10.8 | - | 28.5 | <0.001 |
Fig 5Annual predicted and observed mortality in septic (qSOFA≥1) patients without malaria, 2012–2019.